compare glp-1 Table 1 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review PDB-101: Molecule of the Month:

Hydrogel Nanoparticles and Mass Spectrometry to Explore Low Abundance Proteins in Conditioned Medium from Breast DCIS Tissue Culture

Ann Thorac Surg 105(2):418-424, 2018

Health Canada approves Victoza as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease

Refrigerated or frozen storage is preferred for long-term peptide stability

As a general principle, most DPP-4 inhibitors require dose reduction or avoidance in moderate-to-severe renal impairment

Depending on the case, they may also order tests for kidney function, liver function, muscle enzymes, blood sugar, or genetic conditions